This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mune, T. Articles by Yasuda, K. Search for Related Content PubMed PubMed Citation Articles by Mune, T. Articles by Yasuda, K.

Eutopic Overexpression of Vasopressin V_1a Receptor in Adrenocorticotropin-Independent Macronodular Adrenal Hyperplasia

Third Department of Internal Medicine (T.M., A.M., T.S., J.H., H.D., H.M., K.Y.), Gifu University School of Medicine, Gifu 500-8705; Department of Internal Medicine (H.M.), Daiyukai Hospital, Ichinomiya, Aichi 491-8551; Department of Internal Medicine (N.Y.), Matsunami General Hospital, Kasamatsu, Gifu 501-6062; First Department of Internal Medicine (T.F.), Okayama University, Okayama 700-8558; and Department of General Medicine (M.M.), Gifu Prefectural Hospital, Gifu 500-8717, Japan

Address all correspondence and requests for reprints to: Tomoatsu Mune, M.D., Ph.D., Third Department of Internal Medicine, Gifu University School of Medicine, 40 Tsukasa-machi, Gifu 500-8705, Japan. E-mail: mune{at}cc.gifu-u.ac.jp.

Abstract

Arginine vasopressin (AVP) stimulates cortisol secretion through its vascular type V_1a receptor in the adrenal glands, in addition to stimulating ACTH secretion through pituitary V₃ receptor. Because hyper-response of plasma cortisol to vasopressin is documented in some patients with Cushing’s syndrome due to adrenal adenoma (CS) or ACTH-independent macronodular adrenocortical hyperplasia (AIMAH), we analyzed the expression of V_1a, V₂, V₃ receptor and AVP mRNA in human adrenal tissues by quantitative competitive RT-PCR or real-time PCRs. V_1a receptor mRNA levels (ratio against glyceraldehyde 3-phosphate dehydrogenase) were 0.378 ± 0.143 (mean ± SE) in preclinical CS (n = 5) and 0.630 ± 0.072 in AIMAH (n = 4), which were significantly higher than those (0.046 ± 0.012; n = 9) in control adrenals, whereas those in overt CS (0.143 ± 0.048; n = 10) or aldosterone-producing adenomas (0.069 ± 0.018; n = 12) were similar to control adrenals. Although ectopic expression of V₂ or V₃ receptor was detected in half of AIMAH cases, the absolute levels were low. Furthermore, V_1a receptor mRNA levels in the adjacent adrenal glands (0.190 ± 0.039, n = 9) of aldosterone-producing adenomas were higher than those in control adrenals and in the corresponding tumor portions (0.079 ± 0.024). In contrast, there were no significant differences in AVP mRNA levels among these groups.

These results suggest that eutopic V_1a receptor overexpression is involved in the etiology of AIMAH and a subset of adrenal adenomas causing overt or preclinical Cushing’s syndrome. Our results imply a possible association of V_1a receptor expression with adrenal hyperplasia.

This article has been cited by other articles:

				A. Lampron, I. Bourdeau, S. Oble, A. Godbout, W. Schurch, P. Arjane, P. Hamet, and A. Lacroix Regulation of Aldosterone Secretion by Several Aberrant Receptors Including for Glucose-Dependent Insulinotropic Peptide in a Patient with an Aldosteronoma J. Clin. Endocrinol. Metab., March 1, 2009; 94(3): 750 - 756. [Abstract] [Full Text] [PDF]

				O Zwermann, Y Suttmann, M Bidlingmaier, F Beuschlein, and M Reincke Screening for membrane hormone receptor expression in primary aldosteronism Eur. J. Endocrinol., March 1, 2009; 160(3): 443 - 451. [Abstract] [Full Text] [PDF]

				E Louiset, V Contesse, L Groussin, D Cartier, C Duparc, V Perraudin, J Bertherat, and H Lefebvre Expression of vasopressin receptors in ACTH-independent macronodular bilateral adrenal hyperplasia causing Cushing's syndrome: molecular, immunohistochemical and pharmacological correlates J. Endocrinol., January 1, 2008; 196(1): 1 - 9. [Abstract] [Full Text] [PDF]

				P. Ye, B. Mariniello, F. Mantero, H. Shibata, and W. E Rainey G-protein-coupled receptors in aldosterone-producing adenomas: a potential cause of hyperaldosteronism J. Endocrinol., October 1, 2007; 195(1): 39 - 48. [Abstract] [Full Text] [PDF]

				D Vezzosi, D Cartier, C Regnier, P Otal, A Bennet, F Parmentier, M Plantavid, A Lacroix, H Lefebvre, and P Caron Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors Eur. J. Endocrinol., January 1, 2007; 156(1): 21 - 31. [Abstract] [Full Text] [PDF]

				V. Perraudin, C. Delarue, H. Lefebvre, J.-L. Do Rego, H. Vaudry, and J.-M. Kuhn Evidence for a Role of Vasopressin in the Control of Aldosterone Secretion in Primary Aldosteronism: in Vitro and in Vivo Studies J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1566 - 1572. [Abstract] [Full Text] [PDF]

				J. Bertherat, V. Contesse, E. Louiset, G. Barrande, C. Duparc, L. Groussin, P. Emy, X. Bertagna, J.-M. Kuhn, H. Vaudry, et al. In Vivo and in Vitro Screening for Illegitimate Receptors in Adrenocorticotropin-Independent Macronodular Adrenal Hyperplasia Causing Cushing's Syndrome: Identification of Two Cases of Gonadotropin/Gastric Inhibitory Polypeptide-Dependent Hypercortisolism J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1302 - 1310. [Abstract] [Full Text] [PDF]